These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11806995

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mechanisms of action of recombinant activated factor VII in the context of tissue factor concentration and distribution.
    Ovanesov MV, Panteleev MA, Sinauridze EI, Kireev DA, Plyushch OP, Kopylov KG, Lopatina EG, Saenko EL, Ataullakhanov FI.
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):743-55. PubMed ID: 19002040
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recombinant factor VIIa addition to haemophilic blood perfused over collagen/tissue factor can sufficiently bypass the factor IXa/VIIIa defect to rescue fibrin generation.
    Li R, Panckeri KA, Fogarty PF, Cuker A, Diamond SL.
    Haemophilia; 2017 Sep; 23(5):759-768. PubMed ID: 28475272
    [Abstract] [Full Text] [Related]

  • 7. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K, Nakatomi Y, Araki T, Teshima K, Nakano H, Nakagaki T, Miyamoto S, Funatsu A, Iwanaga S.
    Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
    Hoffman M, Monroe DM, Oliver JA, Roberts HR.
    Blood; 1995 Sep 01; 86(5):1794-801. PubMed ID: 7655009
    [Abstract] [Full Text] [Related]

  • 14. Recombinant factor VIIa does not induce hypercoagulability in vitro.
    Gallistl S, Cvirn G, Muntean W.
    Thromb Haemost; 1999 Feb 01; 81(2):245-9. PubMed ID: 10064000
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. How factor VIIa works in hemophilia.
    Butenas S, Brummel KE, Bouchard BA, Mann KG.
    J Thromb Haemost; 2003 Jun 01; 1(6):1158-60. PubMed ID: 12871314
    [Abstract] [Full Text] [Related]

  • 17. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M, Monroe DM.
    Dis Mon; 2003 Jan 01; 49(1):14-21. PubMed ID: 12525825
    [Abstract] [Full Text] [Related]

  • 18. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
    Sørensen B, Ingerslev J.
    J Thromb Haemost; 2004 Jan 01; 2(1):102-10. PubMed ID: 14717973
    [Abstract] [Full Text] [Related]

  • 19. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M, Monroe DM.
    Semin Hematol; 2001 Oct 01; 38(4 Suppl 12):6-9. PubMed ID: 11735103
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.